TrialThe American journal of gastroenterology2015

A randomized, double-blind, placebo-controlled, phase 3 trial to evaluate the efficacy, safety, and tolerability of prucalopride in men with chronic constipation.

Yan Yiannakou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.